By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
Health Works CollectiveHealth Works CollectiveHealth Works Collective
  • Health
    • Mental Health
  • Policy and Law
    • Global Healthcare
    • Medical Ethics
  • Medical Innovations
  • News
  • Wellness
  • Tech
Search
© 2023 HealthWorks Collective. All Rights Reserved.
Reading: An Insider’s Look at the FDA
Share
Notification Show More
Font ResizerAa
Health Works CollectiveHealth Works Collective
Font ResizerAa
Search
Follow US
  • About
  • Contact
  • Privacy
© 2023 HealthWorks Collective. All Rights Reserved.
Health Works Collective > Business > An Insider’s Look at the FDA
Business

An Insider’s Look at the FDA

Andrew Schorr
Andrew Schorr
Share
4 Min Read
SHARE

If you’ve read my blogs for a while, or look up some past blogs, you’ll see I have been frustrated at times with the FDA. Yes, they have a tough job protecting us from medical products that are unsafe and/or ineffective. But when it comes to cancer, where we have few “homerun” therapies, I wish they were a bit more liberal. A “bunt single” might be good enough. You may have read how I have been critical of Dr.

If you’ve read my blogs for a while, or look up some past blogs, you’ll see I have been frustrated at times with the FDA. Yes, they have a tough job protecting us from medical products that are unsafe and/or ineffective. But when it comes to cancer, where we have few “homerun” therapies, I wish they were a bit more liberal. A “bunt single” might be good enough. You may have read how I have been critical of Dr. Rick Pazdur, the FDA leader for oncology drug approval. Some desperate patients and family members have referred to him as “Dr. No.”

Just the other day I interviewed a respected breast cancer survivor and patient advocate who has high respect for Dr. Pazdur. Musa Mayer of New York City is a 22-year breast cancer survivor and author of three books about breast cancer. She’s devoted her life to educating other patents about cancer and also playing a role in public policy. She has become a favorite patient representative on FDA cancer advisory boards and regularly weighs in when breast cancer drugs are being considered.

In my interview with Musa she explained how difficult it is for the FDA, how they must set the bar very high to maintain public trust and public safety. She says it costs drug companies hundreds of millions of dollars to get a drug through development, clinical trials and FDA review. The process does not move fast. Musa explains why. And she also explains why patients should not have false hope about clinical trials. She maintains their usefulness is to answer specific scientific questions but that seeing it as for sure that you will get “tomorrow’s medicine today” only creates false hope.

More Read

Kiosk Offers Health Assessment
Another Pan Mass Challenge Enters the History Books
Who Knew? Facebook Tops HCAHPS as Measure of Care
Wellbeing Starts in the C-Suite
Patient Survey Shows How Patients Use Online Information

I asked Musa if she was optimistic that drugs could be approved faster, and therefore save and prolong more lives. She said yes. Her reason is that more drug companies are making sure there’s a diagnostic test to go along with their proposed new drug. That way the drug is used on the subset of patients who have the specific cancer variation where the drug works best. That kind of targeted therapy is what the FDA is looking for now and the right test, on the right patient, who is then treated with the right drug could present very positive results the FDA cannot ignore.

Maybe I am wrong about Dr. Pazdur, and maybe I’ve been unfair to the FDA. I’ll have to re-listen to the interview with Musa. She presents a convincing case. See what you think and let me know!

Wishing you and your family the best of health!

Andrew

TAGGED:cancerFDApharmaceuticals
Share This Article
Facebook Copy Link Print
Share

Stay Connected

1.5kFollowersLike
4.5kFollowersFollow
2.8kFollowersPin
136kSubscribersSubscribe

Latest News

a woman walking on the hallway
6 Easy Healthcare Ways to Sit Less and Move More Every Day
Health
September 9, 2025
Clinical Expertise
Healthcare at a Crossroads: Why Leadership Matters More Than Ever
Global Healthcare
September 9, 2025
travel nurse in north carolina
Balancing Speed and Scope: Choosing the Nursing Degree That Fits Your Goals
Nursing
September 1, 2025
intimacy
How to Keep Intimacy Comfortable as You Age
Relationship and Lifestyle Senior Care
September 1, 2025

You Might also Like

medicaid drug costs
FinanceHealth ReformPolicy & LawPublic Health

Is Managed Care the Answer to Reduce Medicaid Drug Costs?

August 14, 2013
family advisory council
Hospital AdministrationPolicy & Law

Patient Experience: Why You Can’t Mandate Patient-Centeredness

September 19, 2016
hospice care
BusinessHospital AdministrationUncategorized

Understanding the Ins and Outs of Hospice Management

May 17, 2021
there are many reasons to find a medical device company san diego
BusinessMedical DevicesTechnology

5 Reasons to Choose Medical Device Companies from San Diego

May 5, 2022
Subscribe
Subscribe to our newsletter to get our newest articles instantly!
Follow US
© 2008-2025 HealthWorks Collective. All Rights Reserved.
  • About
  • Contact
  • Privacy
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?